DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.

PLoS One · 2014 · PMC3883684 · PMID 24409315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Gemcitabine slightly attenuated CD34 and Ki67 signals, while DUSP1 knockdown had a marked inhibitory effect on CD34 staining and a more moderate but highly significant inhibitory effect on Ki67 staining ( Fig. 7C, 7D ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.